DrugPatentWatch Database Preview
Patent: 10,113,000
Summary for Patent: 10,113,000
| Title: | Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody |
| Abstract: | New combined therapeutic regimens for treatment of B-cell lymphomas are disclosed which comprise, in particular, administration of anti-CD20 antibodies to patients having low-, intermediate- or high-grade non-Hodgkin\'s lymphomas. |
| Inventor(s): | Grillo-Lopez; Antonio J. (South San Francisco, CA) |
| Assignee: | Biogen Inc. (Cambridge, MA) |
| Application Number: | 15/225,594 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,113,000
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech Inc | RITUXAN HYCELA | rituximab; hyaluronidase (human recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | 002 | 2017-06-22 | ⤷ Free Forever Trial | Biogen Inc. (Cambridge, MA) | 2018-08-11 | RX | Orphan | search |
| Genentech Inc | RITUXAN HYCELA | rituximab; hyaluronidase (human recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | 001 | 2017-06-22 | ⤷ Free Forever Trial | Biogen Inc. (Cambridge, MA) | 2018-08-11 | RX | Orphan | search |
| Genentech | RITUXAN | rituximab | SOLUTION;INTRAVENOUS | 103705 | 002 | 1997-11-26 | ⤷ Free Forever Trial | Biogen Inc. (Cambridge, MA) | 2018-08-11 | RX | search | |
| Genentech | RITUXAN | rituximab | SOLUTION;INTRAVENOUS | 103705 | 001 | 1997-11-26 | ⤷ Free Forever Trial | Biogen Inc. (Cambridge, MA) | 2018-08-11 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 10,113,000
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 200101157 | ⤷ Free Forever Trial |
| World Intellectual Property Organization (WIPO) | 0009160 | ⤷ Free Forever Trial |
| United States of America | 2003026804 | ⤷ Free Forever Trial |
| United States of America | 2003206903 | ⤷ Free Forever Trial |
| United States of America | 2008038261 | ⤷ Free Forever Trial |
| United States of America | 2012251534 | ⤷ Free Forever Trial |
| >Country | >Patent Number | >Estimated Expiration |
